This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Knowing where to look for a retirement financial advisor can streamline your search. Learn about the best resources to find qualified professionals.
21,756 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Ford is mounting a renewed effort in a longtime European battleground. This article breaks down the plan, the pitfall...
When a tech insider sells a large stake, investors weigh a range of signals. This guide breaks down what the move cou...
Private firms are now on the front lines of geopolitics as digital and physical infrastructure becomes a battlefield....
A major move by a wealth manager can ripple through markets and tax strategies. Discover what truewealth exits $12.8 ...
Celebrity moments can shape our choices—sometimes inspiring smart budgeting, other times fueling impulse buys. This a...
As the Fed's path becomes less predictable, investors weigh how many rate cuts to expect in 2026. This guide breaks d...
Nebius stock skyrocketed more, driven by demand for AI infrastructure. This guide breaks down the drivers, the number...
Coinbase just rolled out an AI agent to trade crypto on your behalf. This deep dive explains how it works, who it hel...
A fresh milestone has emerged as the crypto markets push toward the global crypto mcap $3.22. XRP leads gains while b...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Two bold players are trying to reinvent how nuclear power sits in the grid. This guide breaks down Nano Nuclear Energ...